$27.44
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Cue Biopharma Names James Ahlers CFO Following FDA Filing for CUE-221 in Food Allergy
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Overview
52-week range
$4.98
$46
55% of range
Avg surprise (last 2)
+4.7%
Avg reaction (last 2)
-8.9%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-24.14 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-1.08 | — | — | -535.3% | -14.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.07 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.09 | $-0.13 | +30.8% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.17 | $-0.14 | -21.4% | — | -3.7% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.17 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.25 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.24 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.29 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.29 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $6M | — | $2M | $3M | $421,000 | — | $3M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-88M | $-5M | — | $-8M | $-9M | $-12M | — | $-9M |
| Net income | $-153M | $-5M | — | $-7M | $-8M | $-12M | — | $-9M |
| EPS (diluted) | $-24.14 | $-1.08 | — | $-0.07 | $-2.67 | $-4.95 | — | $-0.17 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $17M | $16M | $27M | $12M | $27M | $13M | $22M | $32M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $27M | $26M | $37M | $26M | $31M | $16M | $25M | $37M |
| Total assets | $31M | $31M | $42M | $32M | $41M | $22M | $32M | $45M |
| Long-term debt | — | — | — | — | — | — | — | $1M |
| Total liabilities | $28M | $9M | $16M | $18M | $23M | $16M | $15M | $19M |
| Total equity | $2M | $22M | $26M | $13M | $18M | $7M | $17M | $25M |
Implied volatility — last 90 days
No IV snapshots yet for CUE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.